NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Infinity Pharmaceuticals, Inc. 

780 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-453-1000 Fax: 617-453-1001


SEARCH JOBS

View Clinical Trials from BioPharm Insight

The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple cancer indications, all of which represent proprietary applications of our expertise in small molecule drug discovery and development.

We believe that our small molecule discovery and development capabilities, strategic alliances, team of highly experienced management and scientists, and corporate culture form the basis of our potential long-term competitive advantage in seeking to deliver best-in-class medicines to patients.

Small molecule discovery and development capabilities
Our programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation.

Strategic alliances
Building on our strengths in innovative small molecule drug discovery and development, we have established significant strategic alliances with leading pharmaceutical and biotechnology companies to realize the full potential of our product pipeline.

Business and scientific expertise
We have assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business and drug discovery and development.

Culture of citizen-ownership
Our culture and environment of Citizen-Ownership is as important as our technologies. We work together as a community with the shared goal of bringing important new medicines to patients.


 Key Statistics


Email: info@infi.com
Ownership:
Web Site: Infinity Pharmaceuticals, Inc.
Employees: 180
Symbol: INFI
 



Industry
Biotechnology

Segment
Oncology





 Company News
Infinity Pharmaceuticals, Inc. (INFI)'s IPI-504 Named One of Windhover Information Inc. and Campbell Alliance's "Top 10 Projects to Watch" in Oncology 11/17/2009 9:07:45 AM    More...
Infinity Pharmaceuticals, Inc. (INFI) to Present at Upcoming Conferences 11/10/2009 11:00:37 AM    More...
Infinity Pharmaceuticals, Inc. (INFI) Announces Third Quarter 2009 Results Conference Call 11/2/2009 8:49:05 AM    More...
Infinity Pharmaceuticals, Inc. Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors 10/7/2009 8:49:20 AM    More...
Infinity Pharmaceuticals, Inc. to Present At Upcoming Conferences 9/2/2009 9:04:42 AM    More...
Infinity Pharmaceuticals, Inc. Reports Recent R&D Highlights and Second Quarter 2009 Results 8/6/2009 9:15:17 AM    More...
Infinity Pharmaceuticals, Inc. Added to Russell 2000(r) Index 6/29/2009 9:55:16 AM    More...
Infinity Pharmaceuticals, Inc. Reports Encouraging Clinical Data for IPI-504 at American Society of Clinical Oncology 2009 6/1/2009 9:38:32 AM    More...
New Paper in Science Features Infinity Pharmaceuticals, Inc.'s IPI-926 Hedgehog Pathway Inhibitor as a Promising New Approach in Chemo-Resistant Pancreatic Cancer 5/29/2009 9:06:03 AM    More...
Infinity Pharmaceuticals, Inc. Named Winner of The Scientist's 'Best Places to Work in Industry' and Featured in Boston Business Journal's Best Places to Work 2009 Survey 5/27/2009 12:55:44 PM    More...
12345678910...